Follicle Stimulation / Ovulation Induction

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 14, 2026

Follicle stimulation refers to the use of pharmacological agents to recruit follicle development and support ovulation in cycles where the natural process is absent or inadequate. Two principal agent classes are used: oral agents, including clomiphene citrate (a selective estrogen receptor modulator) and letrozole (an aromatase inhibitor); and injectable gonadotropins, preparations containing FSH alone or FSH combined with LH. The appropriate agent class depends on the underlying ovulatory disorder, the clinical method being applied, and how the patient's cycle is being monitored. A 2014 randomized trial in the New England Journal of Medicine found letrozole superior to clomiphene for live birth rates in women with PCOS-related anovulation.¹

Before stimulation is considered, a restorative evaluation asks why ovulation is not occurring. Anovulatory cycles have distinct causes: insulin resistance, thyroid dysfunction, hyperprolactinemia, diminished ovarian reserve, and others. Cycle charting via a fertility awareness-based method supplies the longitudinal picture that a single hormone draw cannot. Treating the underlying cause often restores ovulation without pharmacological stimulation. When stimulation is indicated, named methods like NaProTechnology select the agent and the monitoring approach based on the specific ovulatory disorder rather than applying a one-size protocol.

Cycle monitoring during stimulation is standard. A follicle maturation study tracks follicle growth, identifies poor response early, and guides the decision to add an HCG trigger. Monitoring also reduces the risk of multi-follicular development, which carries meaningful implications when the clinical goal is natural conception rather than oocyte retrieval.

Follicle stimulation in this context is fundamentally different from controlled ovarian hyperstimulation (COH) used in ART protocols. COH intentionally recruits multiple follicles for retrieval and fertilization outside the body. See IVF vs. RRM for a direct comparison of these paradigms. The pharmacological agents may overlap. The clinical objective does not. Restorative stimulation targets one well-developed follicle to support conception within the couple, not to bypass the process that failed.²³

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.